BiotechTube
Home/REGENXBIO/Dr. James M. Wilson
DJ

Dr. James M. Wilson

Co-Founder, Director, Head of Scientific Advisory Board

REGENXBIO

Roles

Co-Founder, Director, Head of Scientific Advisory BoardatREGENXBIO
Co-Founder, Chief Scientific AdvisoratPassage Bio

Therapeutic Areas

OphthalmologyNeurodegenerative DiseasesMetabolic DiseasesRare Diseases

REGENXBIO Pipeline

DrugIndicationPhase
RGX-314Wet Age-related Macular Degeneration (wAMD)Phase 2
RGX-202Duchenne Muscular Dystrophy (DMD)Phase 1/2
RGX-121Mucopolysaccharidosis Type II (MPS II, Hunter syndrome)Phase 1/2
RGX-181Late-Infantile Neuronal Ceroid Lipofuscinosis Type 2 (CLN2 Disease)Preclinical
RGX-381Ocular manifestations of FA Deficiency (FAD)Phase 1/2
ABBV-RGX-314Wet AMD & Diabetic RetinopathyPhase 3

Leadership Team at REGENXBIO

KT
Kenneth T. Mills
President & Chief Executive Officer, Director
PJ
Patrick J. Christmas II, J.D.
Chief Legal Officer & Corporate Secretary
CM
Curran M. Simpson
Chief Operating Officer & Chief Technology Officer
DS
Dr. Steve Pakola
Chief Medical Officer
DO
Dr. Olivier Danos
Chief Scientific Officer (Senior Vice President)
VV
Vittal Vasista, CFA
Chief Financial Officer
DT
Dr. Timothy R. Miller
Co-Founder, Former President & CEO, Director
DK
Dr. Katherine A. High
Co-Founder, Director
DJ
Dr. Jeffrey S. Bartlett
Senior Vice President, Head of Technical Operations
DA
Dr. Alexei A. Lukashev
Vice President, Intellectual Property
View full REGENXBIO profile